Unplanned Readmissions and Long-Term Mortality Risk After Incident Heart Failure Hospitalisation in Western Australia, 2001-2015

被引:2
作者
Weber, Courtney [1 ,3 ]
Hung, Joseph [2 ]
Briffa, Tom [1 ]
Li, Ian [1 ]
Murray, Kevin [1 ]
Hickling, Siobhan [1 ]
机构
[1] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia
[2] Univ Western Australia, Med Sch, Perth, WA, Australia
[3] Clifton St Bldg,Clifton St, Nedlands, WA 6009, Australia
基金
英国医学研究理事会;
关键词
Heart failure; Hospitalisation; Comorbidity; Risk predictors; Mortality; REDUCED EJECTION FRACTION; MANAGEMENT; COMORBIDITY; POPULATION; BURDEN; HEALTH; IMPACT;
D O I
10.1016/j.hlc.2023.04.297
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To investigate the frequency and predictors of unplanned readmissions after incident heart failure (HF) hospitalisation and the association between readmissions and mortality over two years.Methods We performed a retrospective cohort study using Western Australian morbidity and mortality data to identify all patients, aged 25-94 years, who survived an incident (first-ever) HF hospitalisation (principal diagnosis) between 2001-2015. Ordinal logistic regression models determined the covariates independently associated with unplanned readmission(s). Cox proportional hazards models with time-varying exposures determined the hazard ratios (HR) of one or more readmissions for mortality over two years after incident HF.Results Of 18,693 patients, 53.4% male, mean age 74.4 (standard deviation [SD] 13.6) years, 61.3% experienced 32,431 unplanned readmissions (39.7% cardiovascular-related) within two years. Leading readmission causes were HF (19.1%), respiratory diseases (12.6%), and ischaemic heart disease (9.6%). All-cause death occurred in 27.2% of the cohort, and the multivariable-adjusted mortality HR of 1 (versus 0) readmission was 2.5 (95% confidence interval [CI], 2.3-2.7) increasing to 5.0 (95% CI, 4.7-5.4) for 2+ readmissions. The adjusted mortality HR of 1 and 2+ (versus 0) HF-specific readmission was 2.0 (95% CI, 1.8-2.1) and 3.6 (95% CI, 3.2-3.9), respectively. Coexistent cardiovascular and other comorbidities were independently associated with increased readmission and mortality risk.Conclusion This study underlines the high burden of recurrent unplanned cardiovascular and other readmissions within two years after incident HF hospitalisation, and their additive adverse impact on mortality. Integrated multidisciplinary management of concomitant comorbidities, in addition to HF-targeted treatments, is necessary to improve long-term prognosis in HF patients.
引用
收藏
页码:958 / 967
页数:10
相关论文
共 29 条
[1]   Mortality and Readmission Following Hospitalisation for Heart Failure in Australia: A Systematic Review and Meta-Analysis [J].
Al-Omary, Mohammed S. ;
Davies, Allan J. ;
Evans, Tiffany-Jane ;
Bastian, Bruce ;
Fletcher, Peter J. ;
Attia, John ;
Boyle, Andrew J. .
HEART LUNG AND CIRCULATION, 2018, 27 (08) :917-927
[2]   The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries [J].
Ambrosy, Andrew P. ;
Fonarow, Gregg C. ;
Butler, Javed ;
Chioncel, Ovidiu ;
Greene, Stephen J. ;
Vaduganathan, Muthiah ;
Nodari, Savina ;
Lam, Carolyn S. P. ;
Sato, Naoki ;
Shah, Ami N. ;
Gheorghiade, Mihai .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) :1123-1133
[3]   National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018 [J].
Atherton, John J. ;
Sindone, Andrew ;
De Pasquale, Carmine G. ;
Driscoll, Andrea ;
MacDonald, Peter S. ;
Hopper, Ingrid ;
Kistler, Peter M. ;
Briffa, Tom ;
Wong, James ;
Abhayaratna, Walter ;
Thomas, Liza ;
Audehm, Ralph ;
Newton, Phillip ;
O'Loughlin, Joan ;
Branagan, Maree ;
Connell, Cia .
HEART LUNG AND CIRCULATION, 2018, 27 (10) :1123-1208
[4]  
Australia Bureau of Statistics, 2010, Report No.:3412.0
[5]  
Australian Institute of Health and Welfare (AIHW), 2021, Heart, stroke and vascular disease-Australian facts
[6]   Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population [J].
Bradshaw, Pamela J. ;
Stobie, Paul ;
Knuiman, Matthew W. ;
Briffa, Thomas G. ;
Hobbs, Michael S. T. .
OPEN HEART, 2014, 1 (01)
[7]   Gliflozins in the Management of Cardiovascular Disease [J].
Braunwald, Eugene .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (21) :2024-2034
[8]   The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction) [J].
Carson, Peter E. ;
Anand, Inder S. ;
Win, Sithu ;
Rector, Thomas ;
Haass, Markus ;
Lopez-Sendon, Jose ;
Miller, Alan ;
Teerlink, John R. ;
White, Michel ;
McKelvie, Robert S. ;
Komajda, Michel ;
Zile, Michael R. ;
McMurray, John J. ;
Massie, Barry .
JACC-HEART FAILURE, 2015, 3 (06) :429-441
[9]   Multidisciplinary Management of Chronic Heart Failure: Principles and Future Trends [J].
Davidson, Patricia M. ;
Newton, Phillip J. ;
Tankumpuan, Thitipong ;
Paull, G. ;
Dennison-Himmelfarb, Cheryl .
CLINICAL THERAPEUTICS, 2015, 37 (10) :2225-2233
[10]   Influence of Hospitalization for Cardiovascular Versus Noncardiovascular Reasons on Subsequent Mortality in Patients With Chronic Heart Failure Across the Spectrum of Ejection Fraction [J].
Desai, Akshay S. ;
Claggett, Brian ;
Pfeffer, Marc A. ;
Bello, Natalie ;
Finn, Peter V. ;
Granger, Christopher B. ;
McMurray, John J. V. ;
Pocock, Stuart ;
Swedberg, Karl ;
Yusuf, Salim ;
Solomon, Scott D. .
CIRCULATION-HEART FAILURE, 2014, 7 (06) :895-U58